Lectures 1 + 2 - Carcinogenesis, Oncogenes and TSGs Flashcards

1
Q

Name 4 of the hallmarks of cancer

A

Resisting cell death
Activating invasion and metastasis
Inducing angiogenesis
Avoiding immune destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define carcinogenesis

A

Transformation of a “normal” cell to a cancerous cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define mutagenesis

Which stage of carcinogenesis does this equate to?

A

The process of genetic information changing in a stable manner, resulting in mutation
Initiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Give two things that could cause mutations (broadly speaking)

A

Mutagens

Replication errors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How might direct carcinogens cause carcinogenesis?

Give an example of a type of direct carcinogen

A

Alter base sequence or cause strand breakage/cross-linking

Alkylating agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does adduct formation lead to single point mutation?

A

When a carcinogen binds to a base, this forms a DNA adduct.
Binding alters the structure of the base such that it no longer pairs with its normal base partner
For example, C pairs with A instead of G
When the DNA replicates, the A is read - therefore when the new strand forms, T is added
Therefore C has changed to T - single point mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give 3 examples of promoting agents

A

Chemicals
Hormones
Inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain the sequence of carcinogenesis in colorectal cancer

Vogelstein model

A
  • Mutation occurs within epithelial cell of intestinal crypt - leads to inactivation of APC gene
  • This results in increased division, leading to a population of hyperproliferative cells. Therefore the risk of a further mutation is higher
  • This second hit comes in the form of a kras mutation - results in cells with a selective advantage
  • 3rd hit is inactivation of p53
  • Adenoma establishes
  • Accumulation of further mutations results in malignant transformation - adenocarcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give some examples of the normal functions of proto-oncogenes

A

Growth factors
Nuclear proteins
Protein kinases
GF receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the 3 ways in which proto-oncogenes may become oncogenes?
Can you give an example of each?

A
  • Single point mutations - kras
  • Translocation - Bcr-Abl in CML
  • Increased amount of protein due to increased expresion or increased stability - Her2 +ve breast cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is kras?
What is its normal function?
What about when it is mutated?

A

Member of the Ras family of oncogenes
Usually activated when binding occurs at tyrosine-kinase receptors - in turn activates MAPK pathway which results in cell growth
When mutated, becomes constitutively active - activates MAPK pathway without growth factor binding to receptor - uncontrolled cell growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the biology behind CML?

A

Abl gene from chromosome 9 translocates to chromosome 22 - ends up next to Bcr gene. This juxtaposition produces a “fusion” protein which has abnormal tyrosine kinase activity - constitutively active - results in increased phosphorylation of downstream proteins.
(Philadelphia chromosome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How might you treat CML given its biological basis?

A

Tyrosine kinase inhibitor, e.g. Imatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the biology behind Burkitt’s lymphoma?

A

Another translocation - this time MYC gene on chromosome 8 translocates to chromosome 14 - ends up next to IgH gene.
IgH activates MYC - results in inappropriate expression of MYC in B cells - causes B cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do tumour suppressor genes do?

A

Maintain genetic stability via DNA repair, cell cycle control etc…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Outline Knudson’s 2 hit hypothesis

A

Deactivation of TSGs requires two sequential mutations to deactivate the 2 alleles - hence 2 “hits” required.
If cancer is hereditary, germline mutation means that every somatic cell already has one mutation - only requires sporadic mutation in any one of those cells to provide 2nd hit and hence deactivate TSG completely.
If cancer is sporadic, must have 2 random mutations in the same cell to deactivate the TSG - far less likely.

17
Q

How might TSGs be deactivated?

A

Loss of 1st allele usually via deletion - “loss of heterozygosity”
Other allele then deactivated via deletion, mutation or methylation

18
Q

Give 2 examples of TSGs

A

p53

Retinoblastoma protein

19
Q

What is the function of p53?

Hence what happens if it is deactivated?

A

Normally causes cell cycle arrest in G1 in response to DNA damage - allows time for repair
If repair successful, cycle continues, if not, p53 induces apoptosis
Hence if inactive, cell cycle progresses even if DNA damaged

20
Q

What is the function of the retinoblastoma protein?

A
  • Responsible for the major G1 checkpoint - prevents cell entering S phase until it is ready
  • Usually binds to an hence inhibits E2F transcription factors
  • Once cell ready to progress, Rb protein is phosphorylated by CDK-C complexes - becomes inactive, therefore releases E2F - allows cell to enter S phase
    If deactivated by mutations, Rb cannot bind E2F - constitutively active - cell will progress even if it’s not ready
21
Q

What are the roles of p15 and p16 regarding the Rb protein?

A

Both TSGs
Inhibit CDKs - therefore prevents deactivation of Rb protein - remains bound to E2F, inhibiting it
Hence if p15/p16 deactivated, Rb more likely to be phosphorylated, allowing E2F action